课题基金 / 基金详情

DEVELOPMENT REGULATION OF HIV GENE EXPRESSION & LATENCY

DEVELOPMENT REGULATION OF HIV GENE EXPRESSION & LATENCY
HIV基因表达的发育调控
批准号:
3078829
负责人:
Steven L. Zeichner
金额:
$5.86万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-08-01 至 1991-07-31

项目摘要

项目成果

Steven L. Zeichner的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A key difference between congential and adult AIDS is the reduced or absent latency period observed in the congenital disease. Congenital AIDS has reduced or absent latency compared to adult AIDS. As newborn immune responses and lymphocytes differ qualitatively from adult's, this proposal's hypothesis is that newborn lymphocytes contain factors that alter HIV gene expression so that latency can not occur. In an analogous fashion, superinfection with DNA virus or immune stimulation are thought to end latency in adults. Planned studies will compare adult and cord blood lymphocyte-mediated HIV transcription, DNA binding proteins, and identify HIV sequences that interact with cord blood nuclear factors. The goal is to isolate and clone cord blood factors implicated in altered HIV expression and compare them with other factors thought to affect HIV expression. This may provide insight into latency and suggest new therapies. Preliminary results show substantial differences between cord and adult nuclear extract bonding to LTR fragments with regulatory sequences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Globally Appropriate Genome Reduced Killed Whole Bacterial HIV Vaccines
  • 批准号:
    10672822
  • 项目类别:
  • 资助金额:
    $56.53万
  • 财政年份:
    2023
  • 负责人:
    Steven L. Zeichner
  • 依托单位:
Pilot Study of Rectal Microbial Biomarkers for Appendicitis Diagnosis
  • 批准号:
    9064769
  • 项目类别:
  • 资助金额:
    $20.71万
  • 财政年份:
    2015
  • 负责人:
    Steven L. Zeichner
  • 依托单位:
Development of an in vivo screening technology for cancer vaccine immunogens
  • 批准号:
    8508685
  • 项目类别:
  • 资助金额:
    $23.02万
  • 财政年份:
    2011
  • 负责人:
    Steven L. Zeichner
  • 依托单位:
Development of an in vivo screening technology for cancer vaccine immunogens
  • 批准号:
    8304214
  • 项目类别:
  • 资助金额:
    $24.49万
  • 财政年份:
    2011
  • 负责人:
    Steven L. Zeichner
  • 依托单位:
国内基金
海外基金
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
  • 批准号:
    JCZRLH202601177
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
  • 批准号:
    2026JJ80500
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    阳帆
  • 依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
  • 批准号:
    2026JJ81975
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖娇
  • 依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究